Renaissance BioScience Corp., a global leader in bioengineered yeast, announced the grant of a Mexican patent for its yeast-based platform technology that enables low-cost production and effective delivery of RNA. This is the third patent issued for the company's RNA technology, following earlier grants in China and Australia, with additional jurisdictions pending. The patent expands Renaissance's robust intellectual property portfolio of issued and pending patents across multiple end-use markets.
The company's most advanced commercial application of this RNA production and delivery system is a suite of RNAi-based biopesticide products that provide precise, targeted pest control. These products offer a strong environmental safety profile compared with broad-spectrum chemical pesticides, while maintaining competitive production costs at scale. Importantly, the technology integrates smoothly into current farming practices and equipment.
Dr. John Husnik, Renaissance's CSO and Office of the CEO, commented: "This patent from the Mexican office confirms the novelty and importance of our yeast-based RNA technology for producing, protecting and delivering next-generation RNA bioactive molecules. In addition to biopesticides, this platform offers exciting opportunities across a wide range of multi-billion-dollar commercial markets."
The patent underscores Renaissance's commitment to innovation in sustainable agriculture. By enabling targeted pest control with minimal environmental impact, the technology addresses growing concerns over chemical pesticide use. The platform's ability to produce RNA at low cost also opens doors in other sectors, including animal and human health, food preservation, and environmental remediation.
For more information about Renaissance BioScience and its technologies, visit www.renaissancebioscience.com.
